Kaplan–Meier survival analysis showed that 75% of mice were still alive in the R848@M2pep-MPsAFP and anti-PD-1 antibody-treated group at 160 days after tumor inoculation (Fig. 6d), significantly better than other groups. The gene discussed is PDCD1; the disease is neoplasm.